Joachim Lupberger

机构：Inserm, Institute for Translational Medicine and Liver Disease, Université de Strasbourg · ORCID：0000-0003-3996-3907

发表论文 96 篇 · 总被引 3677 次 · h-index 28

代表论文

Targeting the liver clock improves fibrosis by restoring TGF-β signaling (2024 · Journal of Hepatology · 被引 58)
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity (2022 · Science Translational Medicine · 被引 53)
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment (2022 · Journal of Hepatology · 被引 51)
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation (2022 · JCI Insight · 被引 22)
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection (2024 · Nature Communications · 被引 14)
Inflammation-related prognostic markers in resected hepatocellular carcinoma (2023 · Frontiers in Oncology · 被引 13)